Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

16 alpha-(/sup 77/Br)bromoestradiol: dosimetry and preliminary clinical studies

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6783501

An estrogen-receptor-binding radiopharmaceutical, 16 alpha-(/sup 77/Br)bromoestradiol-17 beta, has been used successfully at high specific activity to image carcinogen-induced mammary tumors in rats and in preliminary studies to image breast tumors in patients. The biodistribution of the labeled estrogen in rats and its clearance in a monkey were used to estimate the radiation absorbed doses to a human resulting from administration of the radiopharmaceutical. Preliminary imaging studies in patients with mammary carcinoma show promising results and warrant further development of radiolabeled estrogens, particularly those carrying positron emitters that could permit positron emission tomography--for example /sup 75/Br or /sup 18/F.

Research Organization:
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
OSTI ID:
6783501
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 23:5; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

In vivo comparison of 16 alpha(/sup 77/Br)bromoestradiol-17 beta and 16 alpha-(/sup 125/I)iodoestradiol-17 beta
Journal Article · Sat May 01 00:00:00 EDT 1982 · J. Nucl. Med.; (United States) · OSTI ID:6816762

In vivo comparison of 16. cap alpha. -(/sup 77/Br)bromoestradiol-17. beta. and 16. cap alpha. -(/sup 125/I)Iodoestradiol-17. beta
Journal Article · Sat May 01 00:00:00 EDT 1982 · J. Nucl. Med.; (United States) · OSTI ID:7007018

16. cap alpha. -(/sup 77/Br)bromoestradiol-17. beta. : a high specific-activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors
Journal Article · Wed Dec 31 23:00:00 EST 1980 · J. Nucl. Med.; (United States) · OSTI ID:6677486